Direct-acting antiviral therapy and risk of hepatocellular carcinoma recurrence in patients with chronic hepatitis C

Chang Hun Lee; In Hee Kim

doi:10.5009/GNL210191

Direct-acting antiviral therapy and risk of hepatocellular carcinoma recurrence in patients with chronic hepatitis C

Chang Hun Lee
, In Hee Kim^*

^*Corresponding author for this work

Department of Medicine

Research output: Contribution to journal › Editorial

1 Scopus citations

Original language	English
Article number	gnl210191
Journal	Gut and Liver
Volume	15
Issue number	3
DOIs	https://doi.org/10.5009/GNL210191
State	Published - 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Quacquarelli Symonds(QS) Subject Topics

Medicine

Access to Document

10.5009/GNL210191

Cite this

@article{f1ab2c1902844200af003f753620f310,

title = "Direct-acting antiviral therapy and risk of hepatocellular carcinoma recurrence in patients with chronic hepatitis C",

author = "Lee, \{Chang Hun\} and Kim, \{In Hee\}",

year = "2021",

doi = "10.5009/GNL210191",

language = "English",

volume = "15",

journal = "Gut and Liver",

issn = "1976-2283",

number = "3",

}

TY - JOUR

T1 - Direct-acting antiviral therapy and risk of hepatocellular carcinoma recurrence in patients with chronic hepatitis C

AU - Lee, Chang Hun

AU - Kim, In Hee

PY - 2021

Y1 - 2021

UR - https://www.scopus.com/pages/publications/85105903935

U2 - 10.5009/GNL210191

DO - 10.5009/GNL210191

M3 - Editorial

C2 - 33988131

AN - SCOPUS:85105903935

SN - 1976-2283

VL - 15

JO - Gut and Liver

JF - Gut and Liver

IS - 3

M1 - gnl210191

ER -

Direct-acting antiviral therapy and risk of hepatocellular carcinoma recurrence in patients with chronic hepatitis C

UN SDGs

Quacquarelli Symonds(QS) Subject Topics

Access to Document

Other files and links

Cite this